Lobbying Filing Details

Total Spending

$50,000

Activities

1

Lobbyists

2

Gov't Entities

2

Filing Information
Filing UUID:
ad1670db-1d2f-4bc8-98b2-80c74495c96f
Type:
Q2 - 2nd Quarter - Report
Period:
2014 - 2nd Quarter (Apr 1 - June 30)
Date Posted:
July 18, 2014 at 2:47 PM
Income:
$50,000
Expenses:
$0
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Jeremy Rabinovitz Senior Executive Vice President Government Relations
Registrant
ML STRATEGIES, LLC

Government relations consulting firm

Washington, District of Columbia
Client
ASTELLAS PHARMA US, INC.
Illinois, United States of America
Lobbying Activities (1)
Activity 1
Health Issues

H.R. 4187, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2014; H.R. 4857, Ensuring Equal Access to Treatments Act of 2014

Foreign Entity Issues: Astellas Pharma, Inc. based in Tokyo, Japan and as identified in our Lobbying Registration has an interest as a pharmaceutical company in all of the isues with respect to which Astellas Pharma US has lobbied and listed above.

Lobbyists (2)
  • JEREMY RABINOVITZ
  • ABBY MATOUSEK
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES

Source: LDA.gov, data retrieved November 20, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.